Role of bioresorbable stents in the superficial femoral artery

Journal of Cardiovascular Surgery

Volumn 54, Issue 2, 2013, Pages 225-234

  Vermassen, F ^a   Bouckenooghe, I ^a   Moreels, N ^a   Goverde, P ^b   Schroe, H ^c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ZNA Stuyvenberg   (Belgium)

^c DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

Femoral artery; Peripheral arterial disease; Stents

Indexed keywords

ANTINEOPLASTIC AGENT; EVEROLIMUS; MAGNESIUM; MOLECULAR SCAFFOLD; MYOLIMUS; NOVOLIMUS; POLYCARBONATE; POLYGLACTIN; POLYLACTIC ACID; RAPAMYCIN; UNCLASSIFIED DRUG;

BIODEGRADABLE IMPLANT; CORONARY STENT; CRITICAL LIMB ISCHEMIA; DRUG ELUTING STENT; HUMAN; IDEAL STENT; IGAKI TAMAI STENT; METAL STENT; MULTICENTER STUDY (TOPIC); REVA STENT; REVIEW; SELF EXPANDING STENT; SLOW DRUG RELEASE; STANZA STENT; SUPERFICIAL FEMORAL ARTERY STENT;

ABSORBABLE IMPLANTS; EQUIPMENT DESIGN; FEMORAL ARTERY; HUMANS; LACTIC ACID; METALS; PERIPHERAL VASCULAR DISEASES; POLYCARBOXYLATE CEMENT; POLYMERS; STENTS; TISSUE SCAFFOLDS;

EID: 84877315271     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-88. (Pubitemid 43872689)
2. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M et al. Nitinol Stent Implantation vs. Balloon Angioplasty for Lesions in the Superficial Femoral and Proximal Popliteal Arteries of Patients With Claudication: Three-Year Follow-up From the RESILIENT Randomized Trial. J Endovasc Ther 2012;19:1-9.
3. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5. (Pubitemid 40094743)
4. Morice M, Serruys PW, Sousa JE, Fajadet J, Hayashi EB, Perin M et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80. (Pubitemid 34586912)
5. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB et al. Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease Twelve-Month Zilver PTX Randomized Study Results. Circ Cardiovasc Interv 2011;4:495-504.
6. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long-term results from the SIROCCO trial. J Endovasc Ther 2006;13:701-10. (Pubitemid 44907633)
7. Lammer J, Bosiers M, Zeller T, Schillinger M, Boone E, Zaugg MJ et al. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg 2011;54:394-401.
8. Onuma Y, Ormiston J, Serruys PW. Bioresorbable scaffold technologies. Circulation 2011;75:509-20.
9. Ansel G. 3-Year VIBRANT Results for Bare Stents and Stent Grafts in Long SFA Disease. Endovascular Today. October 2011.
10. Minar E, Schillinger M. Innovative technologies for SFA occlusions: drug coated balloons in SFA lesions. J Cardiovasc Surg (Torino) 2012;53:481-6.
11. Ormiston JA, Serruys PWS. Bioabsorbable coronary stents. Circ Cardiovasc Interv 2009;2:255-60.
12. Lincoff AM, Furst JG, Ellis SG, Tuch RJ, Topol EJ. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 1997;29:808-16. (Pubitemid 27128255)
13. Bourantas CV, Zhang Y, Farooq V, Garcia-Garcia HM, Onuma Y, Serruys PW. Bioresorbable Scaffolds: Current evidence and ongoing clinical trials. Curr Cardiol Rep 2012;14:626-34.
14. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S et al. Initial and 6-month results of biodegradable poly-1-lactic acid coronary stents in humans. Circulation 2000; 102: 399-404. (Pubitemid 30490677)
15. Nishio S, Kosuga K, Igaki K, Okada M, Kyo E, Tsuji T et al. Long-Term (> 10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly-1-Lactic Acid Coronary Stents Igaki-Tamai Stents. Circulation 2012;125:2343-52.
16. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373:897-910.
17. Ormiston JA, Serruys PW, Onuma Y, van Geuns RJ, de Bruyne B, Dudek D et al. First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold A Multi-Imaging Modality Study. Circ Cardiovasc Interv 2012;5:620-32.
18. Brugaletta S, Heo JH, Garcia-Garcia HM, Farooq V, van Geuns RJ, de Bruyne B et al. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? Eur Heart J 2012;33:1325-33.
19. Grube E. Bioabsorbable stent. The Boston Scientific and REVA technology. In: EuroPCR 2009. Barcelona; 2009.
20. Jabara R, Pendyala L, Geva S, Chen J, Chronos N, Robinson K. Novel fully bioabsorbable salicylate-based sirolimus-eluting stent. EuroIntervention 2009;5(Suppl F):F58-F64.
21. Verheye S. Desolve first in-man study preliminary results. PCR focus group on bioresorbable scaffolds. Rotterdam NL, March 2012.
22. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 2007;369:1869-75. (Pubitemid 46829357)
23. Hande M. from PROGRESS to DREAMS. PCR focus group on bioresorbable vascular scaffolds. Rotterdam. March 2012.
24. Bosiers M, Investigators AMSI. AMS INSIGHT-Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis. Cardiovascular and Interventional Radiology 2009;32:424-35.
25. Biamino G, Schmidt A, Scheinert D. Treatment of SFA lesions with PLLA biodegradable stents: results of the PERSEUS study. J Endovasc Ther 2005;12(Suppl):5.
26. Werner M. GAIA-DEB Study. 6 month results. Communication at Leipzig Interventional Course 2012.
27. Scheinert D. Esprit I Clinical study. 30 day results. Communication at Leipzig Interventional Course 2013.
28. Holden A. First experience with a bioabsorbable stent for the superficial femoral artery. Communication at Charing Cross International Symposium 2012.